.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has filed to d...
.Aelis Farma's chances of getting an easy, favorable decision on a $100 thousand possibility remitta...
.ProKidney has actually quit some of a set of period 3 tests for its cell therapy for renal disease ...
.Vaxcyte revealed what experts named "spectacular" stage 1/2 information for its own 31-valent pneum...
.Recursion has stumbled by means of a very early test of its own tech-enabled method to medicine exp...
.Contact it a situation of great chemical make up: Acepodia, a biotech based on Nobel Prize-winning ...
.Praxis Preciseness Medicines has actually racked up another midphase gain in epilepsy this year, al...
.After leaving a clinical grip numerous years back, Dyne Rehab has revealed brand-new period 1/2 dat...
.Arrowhead Pharmaceuticals has actually shown its own hand ahead of a prospective showdown with Ioni...
.Pfizer and also Valneva may have concerning 2 more years to stand by prior to they make the 1st app...